Introduction
Notwithstanding the enlightenment of our times, the 'Group of Schizophrenias' presents an enigma and a challenge of enor mous proportions to medical research. Of the so-called functional disorders this dis ease or spectrum of disease entities must be considered the most malignant. Psycho analytic theory, which has provided a use ful conceptual model of the mind and a therapy successful in treatment of the most benign disorders, cannot be regarded as a panacea.
At the present time the schizophrenic psychoses account for more than half the patients in mental hospitals (34). This re presents more than twenty-five per cent of all hospitalized patients. Until the advent of antipsychotic drugs in our therapeutic armamentarium the diagnosis of schizo phrenia frequently implied a lifetime of incarceration, under what might be termed inhuman conditions. Now, many of these patients can be returned, socially cured, to the community and their families, to lead lives that are useful and certainly less pain ful in a psychic sense (14, 64) . Biochem istry, which has had notable success in other areas of medicine, has appropriately been brought to bear on this one. The ability of many simple chemical substances to pro duce a toxic psychosis (psychotomimetic) which simulates schizophrenia in some as pects, has generated the hope that a rela tively simple chemical substance may prove to be the etiological agent. Heuristic hypo theses formulated on such a premise are important because of the interest, thought and research which they stimulate. Dr. Kety (34) cautions us that the provocative evi dence on which they rest may lead to pre-*Manuscript received August, 1969. 1 Sinai Hospital of Detroit, Mich. Canad. Psychiat. Ass. J. Vol. IS (1970) mature convictions regarding the nature of etiologic components of schizophrenia. There is the possibility that this kind of thinking may detract attention from and hinder research in the elucidation of more complex concepts.
In retrospect, however, one can see the application of this rationale in view of our present recognition of psychotic states based on, for example, thyroid dysfunction or lues, that once were regarded in the same light as contemporary 'functional' disorders. It may be that Kraepelin, who was initially responsible for crystallizing the concept of dementia praecox, was prophetic in the sense that he felt that this syndrome was ultimately based on a faulty metabolism. The concept of a chemical cause of schizo phrenia is, however, as old as the Hippocratic School, c. 400 B.C. (63) . The idea gained further impetus after Thudicum (1864), considered to be the founder of modern neurochemistry, postulated that insanity was caused by poisons fermented within the body and that chemical studies could isolate the poisons and discover anti dotes.
The purpose of this review is to draw attention to this field, recognizing the psy chogenic orientation of the readers. The broad research areas involved in the appli cation of biochemical studies to schizo phrenic illness are outlined.
Elucidation of a biochemical approach
Since the beginning of the century the view that chemical principles should be applied as intensively to the elucidation of nervous and mental processes as they have been applied to the study of other living processes, has developed rapidly. In 1909 Jacques Loeb, one of the proponents of this view, stated:
"The scientific analysis of physical pheno mena must aim to explain these pheno mena according to the laws of physical chemistry. We must undertake and carry out a physiochemical analysis of psychi cal phenomena." Biochemical approach in the field of neurology and psychiatry has proceeded along various vectors. One approach in volves the analysis of the chemical com position of blood as an aid in the diagnosis or understanding of pathogenesis (28, 3). In the hands of some investigators it has been as direct as attempting to determine whether, in a given condition, the level of a particular substance in the blood differed from the normal. Similar consideration of cerebrospinal fluid and study of the meta bolism of the brain cell and associated energy changes have also been attempted.
Another approach has entailed study of the chemical composition of the brain. For these investigators it has been as complete as aiming to define the particular disarray of the chemical reactions going on within the disordered neuron. Through animal ex perimentation, they have painstakingly un dertaken to create a store of fundamental knowledge concerning the chemical com position, the energy production, the utili zation of oxygen and the role of enzyme systems associated with nervous activity. All of this has been an attempt to seek a possible basis for an interpretation and un derstanding of pathological processes in man. This latter approach has had a long history and has aimed at supplying infor mation regardless of its potential.
Two main lines of research endeavour appear currently prominent and will be con sidered in this paper. The first involves the study of abnormalities in plasma proteins, while the second deals with disturbances in amine metabolism.
Plasma protein anomalies

Ceruloplasmin and Taraxein
Ceruloplasmin was found to be a coppercontaining alpha-globulin, present in normal human serum. The possibility that abnormal copper metabolism might be involved in the etiology of schizophrenia was first raised when it was found that the level of copper was increased in the serum of schizo phrenics (39, 54). This serum copper was in the form of the copper-containing globu lin, ceruloplasmin.
Interest was generated by the discovery in 1958 by Heath and his group (24) of an abnormal protein constituent of the blood in schizophrenic patients, which was capable of causing some of the symptoms of that disorder when injected into nonschizophrenic volunteers. This was named 'taraxein' and was considered to be a quali tatively different form of ceruloplasmin (39). Members of this group found rapid clinical improvement following intravenous injection of normal ceruloplasmin (24). This has not been substantiated by other researchers who have tried in vain to iso late the elusive 'taraxein' and have there fore dismissed the theory. An attempt by Robbins, Smith and Lowe (51) to repli cate the production of psychotic symptoms in volunteers by means of taraxein, in which they used comparable numbers and types of subjects and equally rigorous con trols, was quite unsuccessful.
Another group postulates that schizo phrenics possess a number of enzymatically active derivatives of ceruloplasmin (iso enzymes) which are responsible for the in creased activity of the ceruloplasmins in the blood of schizophrenic patients (48). This was based on oxidative studies of the blood of normal and schizophrenic patients (sub strate = p-phenylenediamine).
Brain Antibody
A number of groups have reported evi dence compatible with the thesis that an abnormal protein is present to a greater extent in the blood of some schizophrenic subjects than in normal subjects and that this substance is capable of producing cer tain behavioural, metabolic or cellular changes in lower animals. Haddad and Rabe (23) found some evidence for an antigenic abnormality in the pooled serum of chronically ill schizophrenic patients, though other investigators were unable to confirm this (34). Precipitin reactions have yielded conflicting results in efforts to find specific proteins in the serum of schizo phrenic patients (41, 45, 56). Seal and Eist (55) have noted elevations of serum protein-bound carbohydrates and hapto globin in schizophrenic patients, and Seal and Swaim (56) have found significant elevations in plasminogen levels in schizo phrenic patients. There have been reports of plasma from schizophrenic patients in terfering with the learning and retention of learning in the rat (7) . Also, similar ex periments have shown a decrease in ropeclimbing activity in rats injected with serum fractions from schizophrenic patients (4). This has not been confirmed by other groups (53), thus showing a lack of speci ficity of this response.
Using a precision-timing task in cebus monkeys, Ferguson and Fisher (17) have demonstrated a highly significant delay in responsiveness as a result of the injection of plasma from catatonic patients.
Correlations Between Taraxein and Brain Antibody
Heath's studies (25) have shown a cor relation between taraxein and the protein 'brain antibody' studies of the other groups. This scientist points to the instability of the taraxein fraction as effecting difficulties in reproducibility and characterization. Recent data suggested an interrelation between the protein and a small molecule released during stress, perhaps a catecholamine or peptide, as being essential to the psychosisinducing activity of taraxein. Heath con siders taraxein an antibody to brain and schizophrenia an immunologic disorder, with accumulation of histamine in the septal region from an antigen-antibody in teraction. He points to the elevation of serum globulin levels at the onset of symp tomatology in acute schizophrenia as being suggestive of activation of immunologic defence mechanisms. The appearance of schizophrenic symptoms in non-psychotic subjects after receiving 'taraxein' may re present the phenomenon of passive trans fer (26). The author postulates that if taraxein acts as antibody to brain, it may do so by interfering with activity of acetyl choline in a way similar to the antibody action on muscle in myasthenia gravis.
At this point we have seen a possible relationship between two previously regard ed, unrelated areas of interest as well as the ease with which one may 'adapt' a theory.
Carbohydrate Metabolism Studies
Investigation into intermediary carbo hydrate metabolism in schizophrenic sub jects has demonstrated a failure in the re gulation of biologic energy production. The schizophrenic population when compared with control subjects manifested an in ability to mobilize adenosine triphosphate (ATP) as an adaptive response to insulin stress (20). Also under insulin stress there is a failure to increase production of fruc tose^-6 diphosphate in schizophrenic patients. By using radioactive glucose label ed at the 1 and 6 carbon positions, it was found that the insulin stress decreased the rate of incorporation of the 1 carbon of the glucose into carbon dioxide by blood from control subjects. This drop did not occur with the blood from schizophrenic patients.
This effect was found to be related to the plasma rather than to the erythrocytes of the schizophrenic patients. Thus, in the ex periments conducted, chicken erythrocytes were used instead of human blood cells. This eliminated the highly variable indivi dual red blood cell, substituted a more uni form tissue and permitted a more accurate evaluation of the oxidative pathways of metabolism, since the chicken erythrocytes, unlike the human, use the tricarboxylic acid cycle (Krebs) in their metabolism.
In addition to studying the conversion of the glucose to carbon dioxide by chicken cells, the ratio of lactate to pyruvate formed from glucose by the chicken cells was in vestigated. The lactate-pyruvate ratios have been used to indicate anaerobicity of meta bolic systems.
As a product of glucose metabolism 3phospho-glyceraldehyde is oxidized to 1,
3-diphosphoglyceric acid, and simultane ously diphosphopyridine nucleotide (DPN
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In the presence of sufficient oxygen and if the hydrogen transport system is func tioning properly, DPN.H is reoxidized to DPN through the transport system. If how ever the oxidative pathway is interfered with, or if the transport system is not func tioning adequately, oxidation involving DPN would cease unless the DPN.H could be reconverted to DPN in some other man ner. In this instance this would be accom plished through the conversion of pyruvic acid to lactic acid. In the presence of an excess of DPN.H, pyruvate is converted to lactate, which obviously affects the lac tate-pyruvate ratio of the surrounding medium. If the oxidation proceeds at' a sufficient rate, an elevated lactate-pyruvate ratio probably indicates that the DPN.H is not being oxidated rapidly enough via the hydrogen transport system.
Lactate-pyruvate ratios from chicken cells incubated in control and schizophrenic
plasma with glucose as a substrate were measured. The conclusions of this study revealed that the ratio of lactate-to-pyruvate was increased when using plasma from schizophrenic subjects as compared with the control study. Since sufficient oxygen was available in the experiments, it can be hypothesized that the schizophrenic plasma interfered with the transport of hydrogen from DPN.H to the oxygen.
One problem involved in extrapolating any far-reaching conclusions is that many conditions affect the lactate-pyruvate ratios and the rate of glucose oxidation. Thiamine deficiency, for example, causes an elevated lactate-pyruvate ratio.
In a later paper (21), the Lafayette Clinic group was able to demonstrate a dif ference in lactate-pyruvate ratio only when the subjects had engaged in moderate exer cise before the blood samples were drawn. No appreciable difference was found when the subjects were at complete rest, in normal activity or exercising vigorously. This, coupled with the fact that exercise affected the ratio in the incubation mixture more than the presence or absence of schizophrenia suggests a need for better definition of what may be a large number of variables involved in this reaction.
Even more recently the Lafayette group has demonstrated a relationship between elevation of lactate-pyruvate ratio and in hibition of the enzymatic succinoxidase activity (40). They suggest that both effects are probably caused by the same substance, an alpha-globulin present in the serum of schizophrenic patients.
Ryan, Brown and Darrell (52) have helped to clarify some of the basic pro cesses involved in the ability of human plasma to affect lactate production of chicken erythrocytes, which is the determin ing variable of the lactate-pyruvate ratio. In the test system, lactate production by aerobic glycolysis did not depend upon in tact erythrocytes, but rather on their hemo lysis. This was caused by an antibody pre sent in variable titer in all human plasma tested. The plasma of schizophrenic sub jects could not be reliably distinguished from that of non-schizophrenic subjects. Thus there is the possibility that the Lafayette results involving a higher anti body titer is more closely related to a his tory of chronic hospitalization, with sensi tization to a larger number of antigens, than to the presence of schizophrenia (34).
Conclusions Regarding Plasma Protein Studies
There is little if any conclusive evidence regarding the 'schizophrenogenic' quality of schizophrenic plasma. Many of the studies have not been confirmed and conflicting reports are rife in the literature. Attempts at fractionating plasma proteins of schizo phrenic subjects (55, 56) and at purifying and characterizing the source of the ab normal biological activities have not yet led to a well-defined protein associated with the disease process. It is conceivable that many of the abnormalities seen thus far are a reflection of stress, exposure to chronic endemic infections, dietary or other adven titious factors which accompany the dis order and are associated with chronic insti tutionalization. In 1962 it was discovered that the urine of patients with early schizophrenia con tains the substance 3, 4-dimethoxyphenylethylamine (DMPEA) (18). This compound is a dimethylate derivative of dopamine and is closely related in structure to mescaline. This group also reported the ability of liver cells in vitro to produce this substance from dopamine. They further reported the excre tion of labeled DMPEA and its metabolite 3, 4-dimethoxyphenylacetic acid by five schizophrenic patients after infusion of Tritium-labeled dopamine (19) .
Mescaline
Other groups (15, 46) have either failed to confirm the presence of DMPEA or have found it to occur also in normal subjects (60) .
A number of studies have been completed which reported the presence of a 'pink spot' having the characteristics of DMPEA in the urine of schizophrenic patients (12, 10). Hospitalized, non-schizophrenic patients were used as controls in these studies. Bio chemical and psychiatric diagnoses were made independently. Results varied from 29 per cent to 55 per cent positive for schizophrenic patients. Non-schizophrenics showed absence of the 'pink spot'. It is known that psychotropic drugs and their metabolites intefere with DMPEA deter minations and one group has reported that a phenothiazine metabolite will produce a false positive test for DMPEA (15) .
The frequency of a positive correlation between 'pink spot' and schizophrenia has, however, varied enormously. Recently sev eral groups (65, 11, 66) have failed to show any significant relationship.
In summary we can see how findings such as the intensification of psychosis in schizophrenic patients by methyl donors, the existence of at least one enzyme capable of transmethylating normal metabolites to psychotomimetic compounds and some evi dence for the excretion of DMPEA by a number of schizophrenic patients, are com patible with the hypothesis that there is some disturbance of biological transmethyl ation in schizophrenia. The specific methyl ated compounds which effected the exacer bation of psychotic symptoms in the schizo phrenics who were given methyl donors have not been identified. A similar test series, using normal subjects, produced no evidence of a psychotic reaction (35). To date this area of investigation would ap pear to be in the main-stream of the field.
Although there has been much evidence for the existence of DMPEA or related compounds in the urine of schizophrenics, one must consider the failure of some groups to confirm this. There is the pos sibility that the positive results represent an artefact of drag therapy and this must be ruled out. Though parenteral administra tions of DMPEA in normal subjects have not proved to be psychotogenic, this does not preclude an effect from higher concen trations locally within the brain. Also, even were it (DMPEA) pathognomonic, its pathogenicity does not necessarily follow.
The Amphetamine Hypothesis
Other data concerning the amines in the phenylalanine metabolic pathways are de serving of attention. The work to be dis cussed was based on the fact that ampheta mine psychosis cannot always be distin guished clinically from schizophrenia. Am phetamine psychoses were found to occur especially after protracted abuse, but acute cases were seen even following a single dose. The work was accomplished by study ing the effects of amphetamine on animals. The entire series of amphetamine experi ments gave rise to many considerations (16) . It was found that stereotyped manners and thinking w e r e quite common symptoms in both schizophrenia and the amphetamine psychoses. Amphetamine was found to pro duce a special pattern of stereotyped move ments, independent of general motor activ ity, in different animal species including primates. It was found that some higher integrated reactions such as conditioned avoidance responses apparently have the same mechanism as the stereotyped move ments. Both schizophrenia and ampheta mine psychoses responded to the same anti psychotic drugs. As a result a certain cor relation between schizophrenia and amphe tamine stereotypes in animals was suggested.
This does not mean that the animal stereo types can be regarded as a form of animal schizophrenia, but the stereotypes may be an expression of the mechanism which in man produces schizophrenia. Amphetamine stereotypes depend on the transmitter dopa mine, while the role of the transmitter sero tonin is unclear. Most notable was the fact that stereotyped movements, similar to those produced by amphetamine, could be pro duced by the transmitters dopamine and serotonin and by fj-phenylethylamine (phenylalanine metabolite) and by tryptamine (trypotophan metabolite).
These investigations led to the sugges tion that schizophrenia may be due to one or more native amines, perhaps occurring in increased amount. On this basis it was also suggested that it might not be necessary to look for abnormal metabolic products. derivates which may have more direct con temporary significance. Serotonin occurs in brain concentrated in the hypothalamus and in the limbic system where it is a transmitter (16) 
Following this line of thinking, there has been found a correlation between the antischizophrenic effect and the anti-stereotype effect of several drugs (16). Applying this to present research, for example, L-methylpara-tyrosin which blocks the conversion of p-tyrosin to dopa-dopamine may also have an anti-schizophrenic effect as suggested by Randrup and Munkvad, who noted that L-MPT not only antagonized the stereo types but simultaneously increased normal activities in rats.
The Serotonin Hypothesis Although it would appear at this point that the serotonin theory per se has been largely discredited in its purest form, a dis cussion of this theory would appear to be warranted. Indeed, this led to work involv ing other amines, indoles and methylated
. The effect of serotonin-neurones on psychic phenomena is not known. Serotonin can be depleted from the brain by administration of reserpine, which inhibits its deposition in the neurones. The concentration of serotonin (5-hydroxytryptamine) is increased by ad ministration of the MAO-inhibitors which interfere with its degredation and also by administration of its precursor, 5-hydroxytryptophan, which penetrates the bloodbrain barrier. Serotonin is present in largest concentrations in the mucosa of the gastro intestinal tract and in the blood platelets.
It acts as a transmitter to smooth muscle. The absolute amounts in the brain are small and thus changes in brain content of this substance cannot be expected to produce noticeable change in urinary excretion (as 5-HIAA).
Wooley and Shaw (67) demonstrated that LSD and other psychotomimetics inhibited serotonin effect on smooth muscle. From this it was assumed that psychotomimetics might have a similar serotonin-blocking ef fect in the brain and that this might be the cause of the psychotomimetic-provoked hal lucinations. This theory was then extra polated to mental disorders such as schizo phrenia, of which the etiology was then suggested to be a result of cerebral sero tonin deficiency arising from a metabolic disorder.
This hypothesis soon met severe difficul ties (16) when it appeared that reserpine, which depletes serotonin from the brain, had an antipsychotic effect. It was also dis covered that several compounds with pro nounced antiserotonin effect did not have hallucinogenic properties.
Other Amine Metabolism Theories
Other aromatic amines and their deriva tives have undergone investigation recently in relation to schizophrenia. The hypothesis previously mentioned, that adrenochrome or other abnormal metabolites of circulating adrenalin are formed in schizophrenia and are important in producing symptoms (31, 44) has received careful scrutiny, made possible by the recently acquired knowledge of normal metabolism of this hormone (34).
No evidence was found for the abnormal metabolism of labeled adrenalin infused into schizophrenic patients (50, 38). In fact one study, which accounted almost entirely for the excreted label in terms of unchanged adrenalin and four metabolites (3-methoxy-4-hydroxymandelic acid, metanephrine, 3, 4-dihydroxymandelic acid and 3-methoxy-4-hydroxy-phenylglycol), found no qualita tive or quantitative differences in this pattern between patients with chronic schizophrenia and normal volunteers (38).
Hoffer and Osmond (32), who attributed an unidentified Ehrlich-positive substance (i.e., an indole) found in urine to a new form of schizophrenia, have had perhaps some dampening of their earlier enthusiasm. O'Reilly and his group (42) have noted a similar positive reaction in the urine of patients with affective psychoses, alcohol ism, character disorders and cancer. Cer tain indoles (indole acetamide and 6hydroxyskatole) earlier found with increased frequency in the urine of schizophrenic pa tients (58) have more recently been reported with a similar frequency in urine of other types of mental patients, and are probably attributable to exogenous or non-diseaserelated factors (13).
It may be interesting also to note that the fascinating hypothesis of psychotomi metic indoles as a cause of schizophrenia is now considered to be in a weak position (15) .
In schizophrenia there may be some significance in tryptamine excretion, since an increase has been found to occur in such patients before a period of exacerbation (5) . An increase in urinary tryptophan meta bolites has also been noted following the administration of methionine (6), and some investigators suggest that the conversion of tryptamine to its hallucinogenic methylated derivative may occur. Most reports, how ever, have indicated an absence of dimethyltryptamine or dimethylserotonin in the urine of schizophrenics (61). This would certainly render this hypothesis somewhat impotent.
Discussion
In presenting a survey sketch of con temporary research which is attempting to apply physical science in the hope of eluci dating a causative metabolic defect in schizophrenia, several obstacles become ap parent. The clinical diagnosis is quite dis similar in the different schools of psychi atry, and hence the label 'schizophrenia' may cover widely different clinical pictures. Until some method of diagnostic standard ization takes place this will continue to pose a real problem. Faurbye (16) suggests that those engaged in research on schizophrenia should devote attention to a clinical des cription of their patients to enable the reader to understand the type of schizo phrenic patient being investigated. Many clinicians regard schizophrenia as a spec trum of diseases, i.e. a conglomerate of etiologically different processes. Certainly the best way to discover such hypothetical etiologic entities is to investigate a group of patients as clinically uniform as possible. The striking resemblance that certain tem poral lobe epilepsies or chronic intoxica tions (bromism, iodism, amphetamine psy chosis, LSD psychosis, and porphyria) bear to schizophrenia suggests that the syndrome may emerge from different etiologic path ways (34). Recognition of such a possibility aids in the interpretation of genetic and biologic findings and would facilitate the characterization of more specific subgroups. Kety (34) points to the usefulness of the concept of congestive failure with its multi focal etiologies, and uses it to justify the concept of schizophrenia.
Heath (27) points out that the absence of specific effective physical treatments for schizophrenia, combined with the great demand for help, have enabled the psycho genic approach to gain prevalence, despite lack of convincing objective data to support it. This is in direct conflict with Manfred Bleuler's hypothesis (9) that a specific cause of schizophrenia has not been found be cause none exists. Bleuler then justifies the psychogenic basis because of therapy where in schizophrenics are treated by attempting to influence a healthy development of ego and a healthy adaptation to reality. Though no one can quibble with each of his state ments, the reasoning certainly would be faulty if this were intended as a rejection of any biochemical theory. Ultimately, the merits of each conceptual model will lie in the efficacy of treatment methods devel oped.
We cannot ignore the psychologic, social and environmental factors which may operate significantly at various stages of the development of schizophrenic disorders. It would appear that exogenous factors may precipitate, intensify or ameliorate the symp toms and thus confound the biologic pic ture.
In an attempt to co-ordinate biochemical with genetic factors we perhaps see the beginning of formulation of a complex model.
The single-gene-single-enzyme concept of the biologic disorder which was encouraged by the very high concordance rate found in monozygotic twins in earlier studies (33) has been in part negated by more recent studies showing 40 per cent or less con cordance (37). A polygenic inadequacy in teracting with particular life situations is suggested as being more compatible with our present knowledge (34). We must bear in mind the possibility that more complex neurochemical, neurophysiologic and psy-Vol. 15, No. 4 chologic interactions may form the biologic substrate of schizophrenia.* Smythies (57) suggests that the current 'sad muddle' which constitutes so much of schizophrenia research might be alleviated if a co-ordinated interdisciplinary and inter-de partmental program were to be established.
Summary and Conclusions
This paper considers various theories currently involved in the elucidation of a possible metabolic disorder in schizophrenia. Currently two concepts appear prominent. The first involves the study of plasma pro tein abnormalities and the second, amine metabolism disturbances.
In the first group work on ceruloplasmin and taraxein has been inconclusive. This has been a consequence of the inability of other researchers to substantiate much of Heath's original work.
Work done involving the postulate of a 'brain-antibody' has been somewhat equi vocal. Heath suggested that his 'taraxein' and brain-antibody are one and the same, and he pointed to the instability of this fraction as the cause of much difficulty. A relationship was proposed between the pro tein (antibody) and a smaller molecule, perhaps a catecholamine in induction of psychosis. There would seem to be some JThe Lafayette Clinic group appear to have co-ordinated two areas of research; that in volving plasma proteins and that of amine meta bolism, in their current theoretical-model. They have found a qualitative difference in the a a globulin fraction of chronic schizophrenic serum. Though quantitatively identical with normals, in schizophrenics there is a difference in the structural configuration of the protein molecule (measured through spectropolarimetry). This is reflected in a 'bridge' formation in the schizophrenic a 2 globulin, possibly due to the presence of an abnormal indole which alters cell membrane permeability. Consequent ly tryptophan and 5-hydroxytryptophan and possibly other amino acid precursors of methyl ated psychotomimetic derivates can enter the cell. This may produce an increased load metabolically favouring the pathogenic pathways. The real defect they feel, may be an enzyme responsible for regulating a a globulin. Work involving carbohydrate metabolism studies has suggested an interference in oxidative metabolism via various enzyme systems and the hydrogen transport system. An alpha-globulin has been implicated.
Little conclusive evidence regarding the schizophrenicrproducing quality of schizo phrenic plasma has been obtained. Many reports have been conflicting while others remain unconfirmed. It is conceivable that many of the abnormalities represent a re flection of adventitious factors which ac company the disorder and are associated with chronic institutionalization. Possible disorders in amine metabolism were re viewed. It has been shown that pathologic transmethylation may occur in schizo phrenia, and it is this area which would appear to show much promise. Studies in volving the metabolism of adrenalin and serotonin have been of major import here.
The results which show intensification of psychosis in schizophrenia by methyl donors, the existence of at least one enzyme capable of transmethylating normal meta bolites to psychotomimetic compounds and equivocal evidence for the excretion of DMPEA by a number of schizophrenic patients are compatible with the hypothesis that some disturbance of biological trans methylation exists in schizophrenia.
Animal experiments on amphetamine stereotypes have suggested that one or more amines among the normal metabolites of phenylalanine and tryptophan are involved in some way in the mechanism of schizo phrenia. This work has also pointed to the transmitter substance dopamine as being the mediator. Research in this area would appear to merit present attention.
The serotonin hypothesis in its purest form was reviewed in the light of its effect on opening other research corridors. The theory suggested that psychosis might be a result of serotonin deficiency arising from a metabolic disorder. This came into dis favour when it was found that reserpine, which depletes serotonin, has an anti psychotic effect.
No evidence was found to implicate the abnormal metabolism of adrenalin, that is the adrenochrome-adrenolutin pathway in the pathogenesis of schizophrenia.
The hypotheses suggesting psychotomi metic indoles as being significant etiologically are currently in a weak position.
Difficulties in standardizing clinical diag noses, and the possibility that schizophrenia represents a spectrum of disease entities of varying etiologies, have been noted as serious obstacles to research in this area.
Certainly it would seem that a co-ordina tion between various research endeavours and hence conceptual models would be of value. Psychological, social and environ mental factors as well as biochemical and genetic factors may all be involved to some degree.
Without doubt, the discovery of a phy sical basis and hence definitive treatment for schizophrenia would be most desirable.
A prophesy of Teller and Denber, who themselves have tried to co-ordinate genetic, physiological and biochemical concepts, pro vides a final note of optimism:
"The future will show that molecular biology not only holds the key to illness with physical symptoms such as cancer, but to mental illnesses as well." (62) On n'a obtenu que peu de preuves concluantes sur la capacite de production schizophrenique du plasma des schizophrenes. Bon nombre de rapports ont donne des resultats contradictoires tandis que d'autres restent a confirmer. II est possible que bon nombre des anomalies constatees soient le reflet de facteurs adventices qui accompagnent ce trouble et sont associes a l'institutionalisation chronique. L'auteur a exa mine les troubles du metabolisme des amines qu'on peut rencontrer. II a ete demontre que la transmethylation pathologique peut se produire dans la schizophrenic et c'est ce secteur qui semble le plus prometteur. Les etudes sur le metabolisme de l'adrenaline et de la serotonine revetent une grande im portance dans ce domaine.
Resume
Cet article examine diverses theories courantes que comporte l'elucidation d'un trou ble metabolique possible dans la schizo phrenic A l'heure actuelle, deux concepts semblent pr6dominants: le premier comporte 1'examen des proteines du plasma et le second, les troubles du metabolisme. Pour ce qui est du premier groupe, les travaux portant sur la ceruloplasmine et la taraxeine ont donne des resultats peu concluants. Cela est attribuable au fait que les autres chercheurs n'ont pu etablir le bienfonde d'une bonne partie des travaux ori-
Les resultats qui montrent l'intensification de la psychose dans la schizophrenic par le moyen des donneurs de methyle, l'existence d'au moins une enzyme capable de transmethyler les metabolites normaux en composes psychotomimetiques, et la preuve equivoque de l'excretion de DMPEA par un certain nombre de schizophrenes, tout cela est compatible avec l'hypothese qu'il existe un trouble de la transmethyla tion biologique chez les schizophrenes.
Les experiences sur des animaux au moyen de stereotypes d'amphetamines ont laisse croire qu'une ou plusieurs amines, parmi les metabolites normaux de la phenylalanine et de la tryptophane, sont mises en cause de quelque facon dans le mecanisme de la schizophrenic. Ces travaux ont egalement fait voir que la substance transmettrice "dopamine" constitue le me-diateur. Les recherches dans ce domaine sembleraient meriter qu'on s'y arrete.
L'hypothese relative a la serotonine, dans sa forme la plus pure, a ete examinee a la lumiere de ses effets sur la promotion d'au tres secteurs de recherche. L'hypothese a laisse croire que la psychose pourrait bien etre le resultat d'une carence en serotonine, decoulant d'un trouble du metabolisme. Cette hypothese a perdu de la f aveur lorsque Ton a constate que la reserpine, qui abaisse le taux de la s6rotonine, avait un effet anti psychotique.
On n'a rien trouve qui mettrait en cause le metabolisme anormal de l'adrenaline, c'est-a-dire, la voie "adrenochrome-adrenolutine" dans la pathogenese de la schizo phrenic L'hypothese voulant que les indoles psy chotomimetiques aient une signification etiologique n'est pas bien appuyee actuellement.
Les difficultes qu'on eprouve a. normaliser les diagnostics de clinique et la possibilite que la schizophrenic represente toute une gamme d'entites pathologiques d'etiologies differentes, ont ete notees comme constituant de graves obstacles a la recherche dans ce secteur.
II semblerait certes utile de coordonner les divers travaux de recherche et, par con sequent, les modeles conceptuels. Des fac teurs psychologiques, sociaux et du milieu ainsi que des facteurs biochimiques et genetiques semblent etre en cause dans une certaine mesure.
II ne fait aucun doute que la decouverte d'une cause physique et done d'un traite ment precis de la schizophrenie serait des plus souhaitable.
In all things you shall find everywhere the Acid and the Alcaly
Hyppocrates Chymacus
Otto Tachenius d. 1670
